Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte C Widemann

Showing results (71-80 of 203) with videos related to

Pageof 21
Sort By:
Blood Advances|July 26, 2022
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairmentCatherine Lai, Diane E Cole, Seth M Steinberg, et al.
Developmental Medicine and Child Neurology|February 14, 2020
Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromasYang Hou, Taryn Allen, Pamela L Wolters, et al.
Cancer|May 13, 2004
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcomaBrigitte C Widemann, Frank M Balis, Beate Kempf-Bielack, et al.
American Journal of Medical Genetics. Part A|May 16, 2015
Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of lifePamela L Wolters, Katherine M Burns, Staci Martin, et al.
European Journal of Medical Genetics|September 12, 2015
Cephalometry in adults and children with neurofibromatosis type 1: Implications for the pathogenesis of sphenoid wing dysplasia and the "NF1 facies"Winnie Cung, Laura A Freedman, Nicholas E Khan, et al.
Pharmacotherapy|October 18, 2013
Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapyBrigitte C Widemann, Stefan Schwartz, Nalini Jayaprakash, et al.
Journal of Neuro-Oncology|December 12, 2007
The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progressionMichael J Fisher, Sandip Basu, Eva Dombi, et al.
Academic Radiology|November 4, 2017
Volumetric MRI Analysis of Plexiform Neurofibromas in Neurofibromatosis Type 1: Comparison of Two MethodsWenli Cai, Seth M Steinberg, Miriam A Bredella, et al.
Therapeutic Drug Monitoring|August 28, 2014
Age-dependent changes in sirolimus metabolite formation in patients with neurofibromatosis type 1Chie Emoto, Tsuyoshi Fukuda, Tomoyuki Mizuno, et al.
Cancer Research Communications|February 16, 2026
BRAFV600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in MiceFrancesco Tomassoni-Ardori, Karlyne M Reilly, Colleen Barrick, et al.
Pageof 21

Showing results (71-80 of 203) with videos related to

Sort By:
Pageof 21
Blood Advances|July 26, 2022
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairmentCatherine Lai, Diane E Cole, Seth M Steinberg, et al.
Developmental Medicine and Child Neurology|February 14, 2020
Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromasYang Hou, Taryn Allen, Pamela L Wolters, et al.
Cancer|May 13, 2004
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcomaBrigitte C Widemann, Frank M Balis, Beate Kempf-Bielack, et al.
American Journal of Medical Genetics. Part A|May 16, 2015
Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of lifePamela L Wolters, Katherine M Burns, Staci Martin, et al.
European Journal of Medical Genetics|September 12, 2015
Cephalometry in adults and children with neurofibromatosis type 1: Implications for the pathogenesis of sphenoid wing dysplasia and the "NF1 facies"Winnie Cung, Laura A Freedman, Nicholas E Khan, et al.
Pharmacotherapy|October 18, 2013
Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapyBrigitte C Widemann, Stefan Schwartz, Nalini Jayaprakash, et al.
Journal of Neuro-Oncology|December 12, 2007
The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progressionMichael J Fisher, Sandip Basu, Eva Dombi, et al.
Academic Radiology|November 4, 2017
Volumetric MRI Analysis of Plexiform Neurofibromas in Neurofibromatosis Type 1: Comparison of Two MethodsWenli Cai, Seth M Steinberg, Miriam A Bredella, et al.
Therapeutic Drug Monitoring|August 28, 2014
Age-dependent changes in sirolimus metabolite formation in patients with neurofibromatosis type 1Chie Emoto, Tsuyoshi Fukuda, Tomoyuki Mizuno, et al.
Cancer Research Communications|February 16, 2026
BRAFV600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in MiceFrancesco Tomassoni-Ardori, Karlyne M Reilly, Colleen Barrick, et al.
Pageof 21